Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what instructions his Department issued to NHS regional gender hubs on prescribing restrictions.

In March 2024, NHS England published its clinical policy on puberty suppressing hormones for children and young people who have gender incongruence and/or gender dysphoria.

This set out that puberty supressing hormones are not available as a routine commissioning treatment option for the treatment of children and young people who have gender incongruence and/or gender dysphoria.